Showing results (341-350 of 382) with videos related to

Sort By:
Pageof 39
Leukemia & Lymphoma|August 30, 2021
A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up resultsArmando López-Guillermo, Miguel Ángel Canales, Ivan Dlouhy, et al.
Leukemia Research|March 26, 2018
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Olga García, Cristina Gil, et al.
Cancer Medicine|October 28, 2017
Progression-free survival at 2 years post-autologous transplant: a surrogate end point for overall survival in follicular lymphomaAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2017
Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab ExposureAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
Journal of Personalized Medicine|April 23, 2022
High-Sensitivity Troponin T: A Potential Safety Predictive Biomarker for Discharge from the Emergency Department of Patients with Confirmed InfluenzaManuel Antonio Tazón-Varela, Jon Ortiz de Salido-Menchaca, Pedro Muñoz-Cacho, et al.
Cancer|April 24, 2019
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA GroupJosep-Maria Ribera, Olga García, María-José Moreno, et al.
Bone Marrow Transplantation|October 29, 2021
A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selectionR Parody, I Sánchez-Ortega, A Mussetti, et al.
Annals of Hematology|April 29, 2017
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluidRicardo Sanchez, Rosa Ayala, Rafael Alberto Alonso, et al.
Hematology/Oncology and Stem Cell Therapy|July 19, 2019
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapyAna Jiménez-Ubieto, Carlos Grande, Dolores Caballero, et al.
European Journal of Haematology|September 30, 2018
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trialsPere Barba, Mireia Morgades, Pau Montesinos, et al.
Pageof 39